A detailed history of Squarepoint Ops LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 65,575 shares of CRL stock, worth $10.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
65,575
Previous 5,100 1185.78%
Holding current value
$10.2 Million
Previous $1.05 Million 1126.69%
% of portfolio
0.02%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $12.1 Million - $15.7 Million
64,179 Added 4597.35%
65,575 $12.9 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $1,031 - $1,343
5 Added 0.36%
1,396 $288,000
Q1 2024

May 15, 2024

BUY
$203.52 - $273.43 $203 - $273
1 Added 0.07%
1,391 $376,000
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $2.4 Million - $3.49 Million
-14,610 Reduced 91.31%
1,390 $328,000
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $2.94 Million - $3.36 Million
16,000 New
16,000 $3.36 Million
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $11.6 Million - $17.3 Million
-57,051 Reduced 92.01%
4,955 $1.06 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $12.5 Million - $17.7 Million
48,948 Added 374.85%
62,006 $17.6 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $4.24 Million - $5.42 Million
12,075 Added 1228.38%
13,058 $4.92 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $9.73 Million - $12 Million
-26,110 Reduced 96.37%
983 $406,000
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $6.44 Million - $8.14 Million
21,893 Added 421.02%
27,093 $10 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $10.8 Million - $12.9 Million
-43,088 Reduced 89.23%
5,200 $1.51 Million
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $8.55 Million - $9.73 Million
38,510 Added 393.84%
48,288 $12.1 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $1.72 Million - $2.21 Million
9,778 New
9,778 $2.21 Million
Q1 2020

May 15, 2020

SELL
$98.9 - $178.34 $2.56 Million - $4.62 Million
-25,922 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $1.74 Million - $2.11 Million
-13,784 Reduced 34.72%
25,922 $3.96 Million
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $741,289 - $851,532
-5,927 Reduced 12.99%
39,706 $5.26 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $3.18 Million - $3.83 Million
25,755 Added 129.57%
45,633 $6.48 Million
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $7.32 Million - $10.3 Million
-69,871 Reduced 77.85%
19,878 $2.89 Million
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $9.43 Million - $12.3 Million
89,749 New
89,749 $10.2 Million
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $419,307 - $480,256
-4,096 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$98.19 - $115.2 $900,991 - $1.06 Million
-9,176 Reduced 69.14%
4,096 $437,000
Q4 2017

Feb 14, 2018

BUY
$100.43 - $118.09 $174,848 - $205,594
1,741 Added 15.1%
13,272 $1.45 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $1.12 Million - $1.26 Million
11,531
11,531 $1.25 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.88B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.